Debunking Industry Myths on Regulatory Science
FDA is moving Regulatory Science into the 21st century. To this end, the Agency is driving innovation of tools, standards, and approaches that facilitate the development of innovative products, provide data and methods to inform regulatory decision-making, and improve guidance to industry.
FDA’s Tina M. Morrison PhD and Axendia’s Daniel R. Matlis discuss the impact of FDA initiatives Advancing Regulatory Science and Innovation on the Life-Sciences industry in this episode of the “Straight from the Source” series.
They also Debunk Industry Myths on Regulatory Science including:
- Regulatory Science is FDA’s way of regulating science
- FDA does not do research
- FDA is not interested in innovative technologies
- FDA does not collaborate with Industry and Academia